Drug Approval | June 06, 2024
Shilpa Biologicals files Type IV DMF of recombinant Human Albumin 20% with USFDA
This novel recombinant has been developed and is a patented novel recombinant Human Albumin 20% process
This novel recombinant has been developed and is a patented novel recombinant Human Albumin 20% process
mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
Bemdaneprocel is the most clinically advanced investigational cell therapy in the U.S. for treating patients living with Parkinson’s disease
Acceptance based on results demonstrated a statistically significant improvement in overall survival versus chemotherapy alone in these patients
Sacubitril and Valsartan Tablets are indicated to reduce the risk of cardiovascular death
Strides’ approval for this product marks the 1st Indian approval from the USFDA for this complex formulation
This marks the first FDA approval of an AI-based brain disorder analysis solution from Korea
Theophylline is used to treat asthma and chronic obstructive pulmonary disease
For use with Hamamatsu Images acquired with the NanoZoomer S360MD slide scanner
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
Subscribe To Our Newsletter & Stay Updated
